Coming into the race I knew I would still have some fatigue in my legs from the prior weekends' race in Ohio. With the usual speed demons toeing the line (Sheppard, Plews, Williams, Thompson) I knew the pace would be fast from the get-go. The race begins with a 2 mile leadout on a fireroad before darting into the singltrack.
After a mile things already began to seperate and by the time we reached the singetrack there were a few small groups formed. I was in the second group with Plews, and 2 other riders. Plews set the pace early on, although I think he was probablt riding easier than i was. I was full throttled to stay on his wheel. I knew I wouldn't be able to hold this up for long, and sure enough after 7 or 8 miles I began to slowly lose sight of him. The other 2 riders and I then began to work with each other, only this time I was the pace setter. Not able to shack them of my wheels we stayed together for the first lap. The Chris Brandt joined us and he moved to the front to set the pace. This is when the fatigue really began to settle in.
I still have yet to master the proper pacing for a XC race. Around mile 28 of the 34 I was fading back and losing time. Trying to push the bigger gears began to really be a challenge, and I couldn't believe how little strength I had in my legs. I crossed the line roughly 20 min. behind Sheppard who won for the 2nd straight race. After siting down I looked at the data on my Cateye HR monitor and noticed that my Avg and Max HR's were lower this race than they were in the 100-mile race the weekend before.
Bruce Rogers and I after checking the results.
Having the ProAir/HFA banner set up turned out to be a success. I have numerous people approach the booth to get some info and ask questions about ProAir/HFA, the #1 albuterol inhaler. As we were taking down the banner, one woman asked if ProAir/HFA was my sponsor, I said yes. She was very happy to hear that a product such as ProAir/HFA would support an athlete. Needless to say she has been using the inhaler for years and even has some friends who do as well. I gave her some discount cards to help save her some money on her next prescriptions.
1 comment:
Please pass this info along to all of your friends and family.
New FDA Policy Endangers Respiratory Patients
http://mayorsam.blogspot.com/2008/06/new-fda-policy-endangers-respiratory.html
Ozone-friendly inhalers could face early demise
http://www.journalgazette.net/article/20090330/BIZ/303309942/1031/BIZ
Benefits vague, problems clear in inhaler ban
http://www.journalgazette.net/article/20090330/BIZ/303309941
Asthma Patients Outraged at Indifference to Problems with New Inhalers:
http://www.consumeraffairs.com/news04/2009/02/asthma_hfa02.html
Olympian Jackie Joyner-Kersee: FDA "Insensitive" to Asthma Patients' Problems:
http://www.consumeraffairs.com/news04/2009/03/asthma_hfa04.html
The number of patient complaints is skyrocketing:
http://www.consumeraffairs.com/health/hfa_inhalers.html
Read the thousands of complaints at this petition:
http://www.ipetitions.com/petition/saveCFCinhalers/signatures.html
Patients at askapatient.com are reporting HFA inhalers as "useless" with a rating of 1.2 on
a scale of 1 to 5 with 5 being the best and 1 being the worst:
http://www.askapatient.com/viewrating.asp?drug=20503&name=PROVENTIL-HFA
You can only wonder if the FDA is trying to kill asthmatics:
http://www.opednews.com/populum/diarypage.php?did=11627
These quotes taken directly from the new drug application for Ventolin HFA.
"In the multiple dose adolescent and adult studies, albuterol HFA showed a numerically smaller improvement in FEV1 than was seen with albuterol CFC"
"There was other evidence that the HFA formulation delivers a lower/less effective dose on a per acutation basis than the CFC product. In the single dose, dose ranging study in adults, and in the single dose methacholine challenge study in adults one and two acutations of albuterol CFC were statistically indistinguishable in terms of effect, whereas significant differences were seen between one and two acutations of albuterol HFA. Finally, the combined adolescent/adult studies showed that the HFA formulation had a longer median time to onset of effect(4.2-9.6 minutes versus 3.6-4.2 minutes), had a shorter duration of effect(1.55-3.30 hours versus 2.29 - 3.69 hours), and was associated with more albuterol 'back up' use than the CFC formulation."
"We note that in the two 12 week clinical trials in adolescents and adults, Ventolin HFA Inhalation Aerosol consistently showed a smaller effect size than Ventolin CFC Inhalation Aerosol"
"Because it is expected that many physicians will prescribe Ventolin HFA Inhalation Aerosol for patients who have previously used the CFC formulation, it would be appropriate to include some description of the relative effectiveness of these two formulations in the product label."
"Unfavorable changes in physical examinations were observed in the ears, nose, and throat category as follows: 8% placebo HFA; 13% albuterol HFA; and 5% albuterol CFC."
Post a Comment